These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 6158076

  • 1. Effect of coronary artery ligation on the pharmacokinetics of N-acetylprocainamide in dogs.
    Lai CM, Reynolds RD, Kamath BL, Calzadilla S, Gupta SD, Look ZM, Yacobi A.
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):369-72. PubMed ID: 6158076
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of procainamide hydrochloride in dogs.
    Papich MG, Davis LE, Davis CA, McKiernan BC, Brown SA.
    Am J Vet Res; 1986 Nov; 47(11):2351-8. PubMed ID: 2431636
    [Abstract] [Full Text] [Related]

  • 3. Tissue distribution of N-acetylprocainamide in rats.
    Yacobi A, Stampfli HF, Lai CM, Kamath BL.
    Drug Metab Dispos; 1981 Nov; 9(3):193-5. PubMed ID: 6166443
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ, Ruo TI.
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [Abstract] [Full Text] [Related]

  • 5. Procainamide pharmacokinetics in beagles: urinary pH dependency and comparison with n-acetylprocainamide.
    Baer DT, Barkus JC.
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):333-6. PubMed ID: 17895
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bioavailability of N-acetylprocainamide from mixed diet in rats.
    Kamath BL, Yacobi A, Gupta SD, Stampfli H, Durrani M, Lai CM.
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):299-308. PubMed ID: 6166034
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies of the fate of tyramine in dogs: the effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine.
    Faraj BA, Dayton PG, Camp VM, Wilson JP, Malveaux EF, Schlant RC.
    J Pharmacol Exp Ther; 1977 Feb; 200(2):384-93. PubMed ID: 839443
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The inotropic actions of N-acetylprocainamide: blockade and reversal by propranolol.
    Lertora JJ, King LW, Donkor KA.
    Angiology; 1986 Dec; 37(12 Pt 2):939-49. PubMed ID: 2433968
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacokinetics of N-acetylprocainamide.
    Connolly SJ, Kates RE.
    Clin Pharmacokinet; 1982 Dec; 7(3):206-20. PubMed ID: 6178545
    [Abstract] [Full Text] [Related]

  • 16. Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease.
    Kates RE, Jaillon P, Rubenson DS, Winkle RA.
    Clin Pharmacol Ther; 1980 Jul; 28(1):52-7. PubMed ID: 6156049
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. N-Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysis.
    Stec GP, Atkinson AJ, Nevin MJ, Thenot JP, Ruo TI, Gibson TP, Ivanovich P, del Greco F.
    Clin Pharmacol Ther; 1979 Nov; 26(5):618-28. PubMed ID: 91468
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.